SCHEMBL179958

SCHEMBL179958

CC(C)(C)[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810053 0.75 TSHR (0.33)
SCHEMBL15661027 0.74
SCHEMBL5925243 0.74
SCHEMBL2400242 0.74
SCHEMBL263794 0.71
SCHEMBL2144119 0.67
SCHEMBL5005529 0.67
SCHEMBL8678865 0.65
SCHEMBL25231320 0.63
SCHEMBL29145 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024243002-A1 LOW PRESSURE CHEMICAL VAPOR DEPOSITION OF SILICON OXIDE LAM RESEARCH CORPORATION (US) 2024-11-28 WO claimed
CN-118852298-B Method for preparing nematode ascarosides and glucoside dimeric pheromone 云南大学 2024-11-22 CN claimed
CN-118852298-A Method for preparing nematode ascarosides and glucoside dimeric pheromone 云南大学 2024-10-29 CN claimed
WO-2024092420-A1 PREPARATION METHOD FOR ((2R,7AS)-2-FLUOROHEXAHYDRO-1H-PYRROLIZIN-7A-YL)METHANOL 上海皓元医药股份有限公司 2024-05-10 WO claimed
US-20140228417-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED 2-ARYLTHIAZOLE CARBOXYLIC ACIDS MAPI PHARMA LTD. (IL) 2014-08-14 US claimed
EP-4673424-A1 LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS Regeneron Pharmaceuticals, Inc. (US) 2026-01-07 EP disclosed
US-20250340580-A1 TETRASACCHARIDES FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF MELIOIDOSIS AND GLANDERS INST NAT RECH SCIENT (CA) 2025-11-06 US disclosed
US-12427209-B2 Dual mode 18F-labelled theranostic compounds and uses thereof PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2025-09-30 US disclosed
US-12351596-B2 Tetrasaccharides for the diagnosis, prevention, and treatment of melioidosis and glanders INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2025-07-08 US disclosed
WO-2024243002-A1 LOW PRESSURE CHEMICAL VAPOR DEPOSITION OF SILICON OXIDE LAM RESEARCH CORPORATION (US) 2024-11-28 WO disclosed
CN-118852298-B Method for preparing nematode ascarosides and glucoside dimeric pheromone 云南大学 2024-11-22 CN disclosed
CN-118852298-A Method for preparing nematode ascarosides and glucoside dimeric pheromone 云南大学 2024-10-29 CN disclosed
EP-0889042-A1 RADICICOL DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1999-01-07 EP disclosed
US-5837056-A Method for growing III-V group compound semiconductor crystal FUJITSU LIMITED (JP) 1998-11-17 US disclosed
US-5656076-A USING SILICON DOPANT THAT INCLUDES A SILICON ATOM BONDED TO AN ALKYL AND A HYDROGEN FUJITSU LIMITED (JP) 1997-08-12 US disclosed
US-5563250-A Cleavable conjugates for the delivery and release of agents in native form NEORX CORPORATION (US) 1996-10-08 US disclosed
US-5141648-A Methods for isolating compounds using cleavable linker bound matrices NEORX CORPORATION (US) 1992-08-25 US disclosed
US-5126373-A Ester or diester of 1,3-butanediol or 1,3-pentanediol; side effect reduction BRUNENGRABER HENRI (US) 1992-06-30 US disclosed
US-5017693-A Methods for introducing a sulfhydryl amino or hydroxyl groups to a compound NEORX CORPORATION (US) 1991-05-21 US disclosed
EP-0005308-A1 Process for the interconversion of intermediates of use in the preparation of prostaglandins ALLEN &amp; HANBURYS LIMITED (GB) 1979-11-14 EP disclosed